ArriVent BioPharma, Inc. (AVBP)

NASDAQ: AVBP · IEX Real-Time Price · USD

20.10

-0.05 (-0.25%)

At close: May 17, 2024, 4:00 PM

20.62

+0.52 (2.59%)

After-hours: May 17, 2024, 6:51 PM EDT

ArriVent BioPharma Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022
Selling, General & Admin	9.71	6.47
Research & Development	64.88	30.43
Operating Expenses	74.59	36.91
Operating Income	-74.59	-36.91
Other Expense / Income	-5.26	-
Pretax Income	-69.33	-36.91
Net Income	-69.33	-36.91
Shares Outstanding (Basic)	2	1
Shares Outstanding (Diluted)	2	1
Shares Change	67.64%	-
EPS (Basic)	-32.38	-28.90
EPS (Diluted)	-32.38	-28.90
Free Cash Flow	-55.84	-43.63
Free Cash Flow Per Share	-26.08	-34.16
EBITDA	-69.33	-36.91
EBIT	-69.33	-36.91

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).